In today’s legal landscape, corporate defendants face heightened anti-corporate sentiment, fueled by public discourse on economic disparity, healthcare, and corporate accountability. The killing of UnitedHealthcare CEO Brian Thompson brought these frustrations to the forefront, revealing deep-seated distrust toward corporations.
Jury selection and trial strategies must account for these anti-corporate biases. By leveraging voir dire to uncover juror attitudes, humanizing corporate defendants, and focusing on case-specific facts, legal teams can better navigate this challenging climate.
Discover key insights from IMS jury consultants Jorge Monroy and Keith C. Pounds, PhD on how corporate defendants can adapt trial strategies to address rising public skepticism.
Find their strategic guidance for corporate defense teams here: https://imslegal.com/articles/anti-corporate-trial-strategy